Circulating Tumor Cells (CTCs) Prognostic Technologies Market -Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020

Transparency Market Research Report Added “Circulating Tumor Cells (CTCs) Prognostic Technologies Market” to its database.

Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Description

This report provides the market analysis for various technologies and applications used for the enrichment and detection of circulating tumor cells (CTCs). The stakeholders of this report include companies and research institutes involved in the production of prognosis kits and research and development activities related to circulating tumor cells technologies as well as the new entrants who wish to enter this market.

The market overview section of the report analyzes the market dynamics and trends such as drivers, restraints and opportunities that would affect the current and future scenario of the CTC technologies market. Porter’s five forces analysis is included in this study to provide thorough analysis about the competitive status, and market attractiveness analysis has been added to describe the market outlook in different geographies. Event impact analysis is provided in this report for a brief understanding of the technological advancements that have taken place in the past and are planned for the future. Value chain analysis of the market is discussed to recognize value-creating activities from a number of processes, which can provide CTC technology a competitive advantage over other technologies.

Circulating tumor cells (CTCs) are specialized rare cells detached from primary tumors and disseminated in the vasculature system of the body, eventually causing metastasis. CTCs are composed of cells that act as seeds for successive development of additional metastatic tumors in essential distant organs, which is a cause of majority of cancer-related deaths. These CTCs are not easily detected, as these are present in less numbers in the blood stream. Tumors shed nearly 1 million circulating tumor cells (CTCs) per gram of tumor tissue. The global circulating tumor cells (CTCs) prognostic technologies market is segmented based on technologies and applications. Moreover, the technology market is further segmented into tumor cell enrichment and tumor cell detection.

Browse Market Research Report:
http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html

Overview of The Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market

Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organs, which is liable for the majority of cancer-related deaths. On the other hand, these fatal rare cells are capable of providing useful information of cancer patients, since their monitoring and detection is valuable for predicting the response to treatment and prognosis as well as staging of the disease. These rare cells are found both in the bone marrow and in peripheral blood of the body. However, the CTCs found in the blood usually have a short survival time as compared to CTCs found in the bone marrow, which makes the analysis of blood sample for CTCs more specific, thus known as “liquid biopsy”. Therefore, detection of CTCs during the progression of the tumor provides a prognostic value of the tumor progression as well as evaluates the efficacy of therapeutic intervention and provides necessary information for developing personalized medicines.

The primary factors driving the growth of the CTCs prognostic technologies market are increasing demand for diagnostic and prognostic technologies coupled with high incidence and prevalence rates of cancer. Furthermore, colossal application scope of these technologies and patient safety are also some of the factors driving the growth of the CTCs prognostic technologies market. Additionally, substantial cost benefit ratio of these technologies and wide use in therapeutic monitoring are some of the other significant factors that are expected to fuel the growth of the CTCs technologies globally. However, some of the important factors that are restraining the growth of this market are high pricing associated with the technologies and stringent regulatory policies.

Fill the form for an exclusive sample of this report:

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2497

The global circulating tumor cells (CTCs) prognostic technologies market is segmented as follows:

Circulating Tumor Cells (CTCs) Prognostic Technologies Market, by Technology

Tumor Cell Enrichment

Filtration

Centrifugation

Immunological & Immunomagnetic Methods

Tumor Cell Detection

Molecular Methods

Optical Methods

Circulating Tumor Cells (CTCs) Prognostic Technologies Market, by Applications

Prostate Cancer

Breast Cancer

Colorectal Cancer

Others (Lung, Ovarian and Pancreatic Cancer)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s